NEOG insider filing: CFO gets 459,713 options, 178,855 shares
Rhea-AI Filing Summary
Neogen (NEOG) reported an insider equity transaction by its CFO. On 11/03/2025, the officer acquired 178,855 shares of common stock at a stated price of $6.29, bringing directly held common shares to 178,855. The filing also shows a grant of stock options for 459,713 shares with an exercise price of $6.29.
According to the footnotes, the options vest in equal annual installments over three years from the grant date, while the performance stock units vest in total at the end of the three-year anniversary of the grant.
Positive
- None.
Negative
- None.
Insights
Routine executive equity grants with three-year vesting; neutral impact.
The CFO reported acquiring 178,855 common shares and receiving options for 459,713 shares at an exercise price of $6.29 on 11/03/2025. These figures reflect standard executive compensation structures that align pay with long-term performance.
Footnotes indicate options vest in three equal annual tranches, and performance stock units vest in full after three years. This design ties realizable value to tenure and performance outcomes.
No cash proceeds to the issuer are disclosed here. Actual dilution and value realization depend on vesting and future stock performance; the excerpt provides no additional timing beyond the vesting schedules.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) | 459,713 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 178,855 | $6.29 | $1.12M |
Footnotes (2)
- F1. Options vest in equal annual installments on each of the first three anniversary dates of the grants
- F2. PSUs vest in total at the end of the three year anniversary date of the grant
FAQ
What insider transaction did NEOG’s CFO report?
What are the exercise price and size of the NEOG options grant?
What are the vesting terms for the options and PSUs at NEOG?
AI-generated analysis. How Rhea-AI works. Not financial advice.